Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial

NCT07542418 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

OTHER: Thiotepa and Melphalan
OTHER: Melphalan

Sponsor

First Affiliated Hospital Xi'an Jiaotong University